StATins Use in intRacerebral hemorrhage patieNts (SATURN)

Clinical Trial Details

The study will look at patients with spontaneous intracranial hemorrhage while taking statins. The patient will then be randomized to continue or discontinue statin therapy to continue to treat the patient after the initial event.

Key Eligibility:

Open to men and women 50 years or older who have been diagnosed with a spontaneous lobar intracranial hemorrhage.
Was taking a statin drug at the onset of the event.
No history or recent myocardial infarction.
Detailed eligibility will be reviewed when you contact the study team.

Return to List

Study contact by location

Upper East Side - Manhattan

Contact(s)

Carla Sherman
(646) 962-8284
cas9149@med.cornell.edu

Primary Investigator(s)

Santosh Bhaskar Murthy, MD, MPH

Protocol ID(s)

Weill Cornell Medicine IRB #:

2001021273

Status

Open to Enrollment

Age Group

Adult

Disease

Hemorrhage

Intracranial Hemorrhage